Editor who opined on author excuses has paper subjected to an expression of concern

A study co-authored by an editor who has previously opined on common excuses by authors about research misconduct has received an expression of concern.

The paper’s first author defended the work, explaining that the experiments in question were repeated multiple times, and that the results are “valid and reproducible.”

The study, titled, “CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions,” was published in Nucleic Acids Research in April 2009. It has been cited 20 times, according to Clarivate Analytics’ Web of Science.

In March 2017, an anonymous user on PubPeer flagged several images in the paper, all of them immunoblots. Georgios Giamas, the study’s first author and now a professor at the University of Sussex, defended the work at that time, writing that he had performed “thousands” of these experiments and that “there were occasions that certain results/data were indeed ‘strangely similar.’” He attributed the similarities in the images to a “technical issue,” explaining that they had “repeated these experiments (as we do for every single one) at least 3x times; therefore, the results/conclusions presented in this manuscript are valid and reproducible.”

After those initial PubPeer comments, Nucleic Acids Research launched an investigation into the study, according to editor-in-chief Keith Fox. Giamas repeated the experiments and shared those new data with the journal, he explained on PubPeer

In May, as the journal’s investigation proceeded, an “unregistered account” responded to the PubPeer whistleblower, signing their message as “Justin Stebbing,” the name of the study’s corresponding author and an oncologist at Imperial College London:

You have an extraordinary amount of time on your hands. Anonymous complaints lose all credibility in my view and as Editor-in-Chief of Oncogene, if complaints remain anonymous they are in general not dealt with. It is cowardly and anyone with conviction should name themselves – this is in accordance with basic principles of justice. We have repeated experiments and written to the journal, Justin Stebbing

Separately, Stebbing, who has not responded to our requests for comment, was recently “accused of inappropriately treating terminally ill cancer patients, in some cases overstating the benefits of treatment or treating patients who had just weeks to live,” according to Medscape. He “has admitted getting too close to a vulnerable cancer patient whom he wrongly treated after telling her she had just months to live,” but denies most of the charges.

In 2017, Stebbing co-authored an article in Oncogene citing eight excuses that he frequently hears as an editor from authors whose research integrity is questioned. One excuse is that the original data are missing — which becomes more valid as time passes — while another is that ‘the results have been replicated by ourselves or others, so the image manipulation is irrelevant.’ 

In July 2017, Nucleic Acids Research said that they were “satisfied” with the authors’ response, and “agree that the figures have not been unethically altered,” according to Giamas. The editors concluded: “We now consider this case closed.”

Then, on February 2 of this year, the case was reopened after science sleuth Elisabeth Bik posted on the PubPeer message board that she agreed with the original whistleblower and would “be happy to testify in person for any research integrity board that the similarities in the figures of this paper are very unexpected, and very, very unlikely to have happened by a technical issue.”

The journal’s second investigation also did not find any “quantitative evidence of image splicing,” according to Fox. Still, the journal issued an expression of concern on March 8, and asked Imperial College London to investigate the paper. The expression of concern reads, in part:

Following comments published on PubPeer, the Editors were first alerted by the Authors in 2017, and more recently by a Reader, that the blots depicted in several figures show unusual levels of similarity.

Details have been published in PubPeer: https://pubpeer.com/publications/1CCAC58543784D1B17C8416A6D97C2

The Authors have not been able to provide the original data. Therefore, following COPE guidelines, we are referring this to the Authors’ institution. The Editors advise Readers to examine the details of this study with particular care.

When we asked Fox why they reopened the case, he sent a statement and asked that it be published in its entirety. It reads:

Thank you for contacting us about this Expression of Concern.

We did investigate the issue in 2017, when we were alerted by a whistle blower and then the authors, of the comments in PubPeer. Using the tools available to us at the time we could find no evidence of image manipulations or splicing that would explain the apparent similarity of some of the bands. The authors also sent a rebuttal to the accusations that the bands were identical. According to COPE guidelines we therefore did not proceed further.

In February 2021 we were contacted by another whistle blower, as well as the authors and so we re-opened the case. While we have still not been able to detect any direct quantitative evidence of image splicing, the author’s most recent response and inability to provide the original data led us to decide that, following COPE guidelines, we should publish an EoC and ask the authors’ institution to investigate.

The Editors of Nucleic Acids Research always take any allegations of fraud or breaches of academic integrity very seriously and we carefully follow COPE guidelines in every instance. If allegations are upheld then we published Expressions of Concern or Retractions, as appropriate.

In response to an email from Retraction Watch, asking if he agreed with the editors’ decision to issue the expression of concern now, and whether he was aware of any image manipulation, Giamas said:

I cannot speak on behalf of NAR about their decision to issue now an EoC, following their previous statement in 2017: ‘We are satisfied with your response and the evidence provided and agree that the figures have not been unethically altered. We now consider this case closed’. Nevertheless, we respect their decision.

Regarding our comments, due to the fact that the original data are not available, we cannot categorically demonstrate that figure editing and image compression did not unnaturally alter the appearance of some of the blots.

Though Giamas said that he had repeated the experiments, and that the study’s results were replicable, he was not willing to share those data with us, saying:

As this is an ongoing investigation, the data have been made available to the journal (as mentioned in our statement) and to Imperial College as well.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].

8 thoughts on “Editor who opined on author excuses has paper subjected to an expression of concern”

  1. https://www.thetimes.co.uk/article/oncologist-nicknamed-god-gave-futile-treatment-to-dying-patients-jr8f0kblb

    “A world-renowned oncologist dubbed “God” because of his pioneering work has been found guilty by a medical tribunal of providing inappropriate treatment to dying patients.

    Professor Justin Stebbing, a cancer medicine and oncology professor at Imperial College London with a private practice in Harley Street, had been accused of failing to provide good clinical care to 12 patients. This included giving treatment when doing so was futile.

    The decision by the Medical Practitioners Tribunal Service was a devastating blow to Stebbing’s reputation. He was found guilty of 33 out of 36 charges, 30 of which he had admitted. The remaining three were not fully proven.

    Sharon Beattie QC, for the General Medical Council, said that Stebbing had failed to consider the “dignity” of patients.”

  2. https://www.dailymail.co.uk/news/article-10073991/Top-oncologist-gets-blistering-tribunal-ruling-treatment-terminally-ill-cancer-patients.html

    “In a scathing 95,000-word judgment, the Medical Practitioners Tribunal Service panel also hit out at two of the country’s most eminent oncologists who gave expert evidence in support of Stebbing.

    It said one, Professor Karol Sikora, had given evidence that was ‘fundamentally incompatible with his duties as an independent and impartial expert’.”

  3. 29th October 2021 Retraction.
    https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkab845/6414044?searchresult=1

    Nucleic Acids Research, Volume 37, Issue 9, 1 May 2009, Pages 3110–3123, https://doi.org/10.1093/nar/gkp136

    Following initial allegations of image manipulation in 2017 in the above article (1) the journal investigated the matter and did not find conclusive evidence to support the allegations. When further allegations were raised in 2021, the journal referred the matter to the authors’ institutions and an Expression of Concern was published in NAR (2). The Editors of the journal are now retracting the article for the following reasons:

    The authors have been unable to produce the original raw image files for either the journal or the institutions.

    The authors’ institutions conducted a formal investigation, and the official report dated 26-Aug-2021 concludes: ‘although the results themselves are not in question (having been verified by the subsequent repeat experiments carried out by the authors), the paper should still be retracted on the basis that the original data is no longer available, and was not available in 2017 when these concerns were first raised.’

    REFERENCES
    1. Giamas G., Castellano L., Feng Q., Knippschild U., Jacob J., Thomas R.S., Coombes R.C., Smith C.L., Jiao L.R., Stebbing J. CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions. Nucleic Acids Res. 2009; 37:3110–3123.

    Fox K.R., Stoddard B.L. Editorial Expression of Concern on article ‘CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions’. Nucleic Acids Res. 2021; 49:3602.

  4. https://uat.standard.co.uk/news/london/justin-stebbing-london-cancer-doctor-harley-street-suspended-misconduct-b973007.html

    By Ross Lydall@RossLydall
    21 December 2021

    An eminent cancer doctor has been suspended from practising for nine months but escaped being struck off after being found guilty of misconduct.

    Professor Justin Stebbing, who worked primarily in the private sector in Harley Street but also at Imperial College NHS trust, was told of the sanction on Monday by the Medical Practitioners Tribunal Service.

    He is currently on holiday in the Caribbean and his barrister, Mary O’Rourke QC, said: “He is not intending to appeal.”

    She had previously told the tribunal that a lengthy suspension was likely to result in him losing his contract at Imperial College London university.

    On Monday afternoon, as the panel reconvened to decide whether to agree to the General Medical Council’s request to make the suspension start immediately, Ms O’Rourke requested a delay to enable Professor Stebbing to “put his affairs in order” for a “seamless departure”.

    But later on Monday the tribunal decided that the suspension should start immediately.

    Panel chairwoman Margaret Obi said in a written statement: “The tribunal determined that an immediate order of suspension is necessary for the protection of the public and is otherwise in the public interest.”

    Professor Stebbing had previously admitted adopting a “cavalier” approach in the way he treated some patients. He also admitted sending “inappropriate” emails to a dying patient he nicknamed LMT (Little Miss Trouble).

    Documents published by the MPTS on Monday morning announced the nine-month suspension.

    It shows the panel rejected erasing Professor Stebbing from the medical register and instead decided on a nine-month suspension as there was a public interest in permitting him to return to practice “as soon as possible”.

    Tribunal chair Hassan Khan said: “The tribunal took the view that a period of suspension would send a clear signal to Professor Stebbing, the public, and the wider profession in order to reaffirm the standards of conduct and behaviour expected of all registered doctors.

    “The tribunal considered the mitigating factors in this case, including that the earliest relevant events took place approximately seven years ago, that Professor Stebbing has shown genuine remorse, has acknowledged his wrongdoing, and has taken considerable steps towards remediation.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.